12 Biggest Mid-Day Losers For Monday - Agios Pharmaceuticals (NASDAQ:AGIO)

Neothetics Inc NEOT shares dropped 69.6 percent to $0.709. Neothetics disclosed that LIPO-202 did not show any improvement on efficacy measurements.
Matinas BioPharma Holdings Inc MTNB shares declined 18.1 percent to $2.27. Matinas BioPharma reported that Phase 2 clinical study of orally-administered MAT2203 for the treatment of vulvovaginal candidiasis did not meet expectations.
Gener8 Maritime Inc GNRT shares tumbled 14.1 percent to $5.26.
Internet Gold Golden Lines Ltd IGLD shares declined 13.1 percent to $9.79.
Seattle Genetics, Inc. SGEN shares dropped 11.2 percent to $54.81. Seattle Genetics disclosed that Phase 3 ECHELON-1 trial met its primary endpoint.
Stratasys, Ltd. SSYS shares dipped 11 percent to $24.56. Goldman Sachs downgraded Stratasys from Neutral to Sell.
Foresight Autonomous Holdings Ltd. FRSX shares declined 11 percent to $9.31.
HealthStream, Inc. HSTM dropped 10 percent to $27.79. HealthStream repoted that Laerdal Medical A/S has ended renewal negotiations for the agreements with HealthStream.
Agios Pharmaceuticals Inc AGIO shares fell 9.7 percent to $53.43. Agios Pharma disclosed updated data from fully enrolled DRIVE PK study demonstrating AG-348's potential as first disease-modifying treatment for patients with PKR at the European Hematology Association. Janney Capital downgraded Agios Pharmaceuticals from Buy to Neutral.
DryShips Inc. DRYS shares dropped 6.6 percent to $2.28 after tumbling 13.78 percent on Friday.
Arconic Inc ARNC shares declined 6.1 percent to $23.98 as the company said in emails it knowingly supplied flammable panels for use in Grenfell Tower.
GrubHub Inc GRUB dropped 6.5 percent to $44.60. Morgan Stanley downgraded GrubHub from Overweight to Equal-Weight.

Market News and Data brought to you by Benzinga APIs